“The nomination of Harmeet Dhillon to lead this critical civil rights office is yet another clear sign that this administration seeks to advance ideological viewpoints over the rights and ...

The Supreme Court will hear arguments next month over the constitutionality of the federal law that could ban TikTok in the U.S. if its Chinese parent company doesn’t sell it The Latest A former ...

During the campaign, Republican Richard M. Nixon and Democrat John F. Kennedy mostly avoided civil rights issues, afraid to alienate Southern voters. In October of that year, civil rights leader ...

The U.N.'s High Commissioner for Human Rights Volker Turk made the announcement at a press conference in Geneva in response to a reporter's question. "We have been able to resume partly our ...

The U.N. office on human rights in Venezuela has partially resumed operations in recent weeks CARACAS, Venezuela -- The U.N. office on human rights in Venezuela partially resumed operations in ...

Under the terms of the agreement, following a specified transition period, Partner Therapeutics will assume full rights to U.S. commercialization ... 1500 mg). The analyst writes that in the ...

A popular petroleum analyst is warning Donald Trump his plan to impose a 25% tariff on all imports from Canada will backfire. Patrick De Haan, known as the “Gas Buddy Guy,” has “analyzed and tracked ...

LIMA — Lima council is calling for resumes for a new civil service board member. Anyone interested in being one of the three board members responsible for administering the city’s civil ...

¥ÿÿW1Ž­ Õ^ ‘¦õf>œ‰ê5€ ã°q¨Þ‡€ªV qwØ«â× ýóߟ À¸û ‚Ñd¶Xmlíì œ]\ÝÜ=½¼}|ýüýgšU ŸËéEj %– x0t[ŠV¹ž ëz ™lÑ` ¤QqÙ±—ãÿ÷ënŠ¦Óšµâ ...

FILE - U.N. and Venezuelan flags hang outside the building that houses the Technical Advisory Office of the United Nations High Commissioner for Human Rights, in Caracas, Venezuela, Feb. 15 ...

In exchange for the rights granted under the license agreement ... and a new dose-comparison cohort (1100 mg vs. 1500 mg). The analyst writes that in the near term, updated data for petosemtamab ...